All In MedTech

Device Trial Radar · NCT07928986

A Multi Center Evaluation of TearCare on Surgical Measurements Before Cataract Surgery

A Multi Center, Peri-Cataract Evaluation of TearCare With Expression on Ocular Biometry and Surgical Measurements

Last checked: Nov 19, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

36

Planned (sponsor's estimate)

Start

Sep 22, 2026

Primary completion

Dec 2026

Study completion Dec 2026

Sponsor

Lead sponsor
Cleveland Eye ClinicAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Sight Sciences, Inc.
First posted
Nov 10, 2026

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 50 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this study is to evaluate whether TearCare treatment stabilizes corneal measurements sufficiently to determine when cataract biometry can be considered reliable.

Conditions

  • Dry Eye Syndrome (DES)
  • Meibomian Gland Dysfunction (Disorder)

Interventions

  • Manual expression of meibomian glands after thermal eyelid therapyDevice

    In this study the TearCare procedure and system is being used to provide thermal eyelid therapy before manual expression by the PI.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To determine the mean change and stability in IOL predicted power calculation using: Barrett Universal II, Kane Formula and Hill-RBFTime frame: 8 weeks from enrollment.

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • The Eye Institute of West Florida

    Largo, Florida · Not yet recruiting

  • Cleveland Eye Clinic

    Brecksville, Ohio · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.